Clinical Trial Update: BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) [Phase 2]

View source ↗

Summary

This update notes that the BMT-06 study of intensity-modulated total marrow irradiation (IM-TMI) is a Phase 2 trial currently recruiting for acute leukemia and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Acute Leukemia, MDS | Phase 2 | Status: RECRUITING